Is cbdMD, Inc. (YCBD) a Buy, Sell, or Hold?
cbdMD, Inc.
AMEX:YCBD
$0.6577 USD
-$0.02 (-3.56%)
- Volume
- 196.4K
- Average Volume
- 1.34M
- Market Capitalization
- $6.9M
- P/E Ratio
- -1.62
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $2.56
- Year Low
- $0.47
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.82
Industry, Sector & symbol
| Stock Exchange | AMEX |
| CEO | T. Ronan Kennedy |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Current Symbol | YCBD |
| CUSIP | 12482W408 |
| CIK | 0001644903 |
| Web | https://www.cbdmd.com |
| Phone | 704 445 3060 |
| Currency | USD |
| Employees | 42 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.04 |
| Payout Ratio | 0.00 |
| Current Ratio | 2.82 |
| Quick Ratio | 1.71 |
| Cash Ratio | 0.89 |
Sales & Book Value
| Annual Sales | $19.19M |
| Price / Sales | 0.35 |
| Cash Flow | -15.94 |
| Price / Cash Flow | -0.04 |
| Price / Book | 0.74 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 3 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-1.09 |
| Trailing P/E Ratio | -1.62 |
| PEG Ratio | -0.02 |
| P/E Growth | -0.02 |
| Net Income | $-2.04M |
| Net Margin | -13.29% |
| Pretax Margin | -13.29% |
| Return on Equity | -33.59% |
| Return on Assets | -21.68% |
Financials Score
| AltmanZ Score | -17.75 |
| Piotroski Score | 3.00 |
| Working Capital | 5.42M |
| Total Assets | 12.25M |
| Ebit | -2.66M |
| Market Cap | 7.16M |
| Total Liabilities | 2.97M |
Poll Results
About cbdMD, Inc. (AMEX:YCBD) Stock
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mort ... ar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
cbdMD's Oasis Brand Partners with Mexcor to Launch Into South Carolina
2026-07-14 09:25:00
Hemp-derived THC beverages, including the new zero-proof Mixer, roll out to liquor retailers statewide CHARLOTTE, N.C., July 14, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD) today announced that its Oasis line of hemp-derived beverages is now available in South Carolina through a new distribution agreement with Morales Beverage Group, South Carolina, a leading beverage statewide alcohol distributor.
2026-07-09 08:25:00
Partnership reinforces Bluebird Botanicals' Colorado roots, environmental values, and commitment to responsible growth under cbdMD leadership CHARLOTTE, N.C., July 9, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD) through its Bluebird Botanicals brand ("Bluebird"), today announced an official partnership with Denver Audubon, a Colorado-based conservation organization dedicated to protecting birds, restoring habitat, advancing community science, and helping transform Denver into a more bird-friendly city.
cbdMD Sets a New Safety Standard for Broad Spectrum CBD With Self-Affirmed GRAS Determination
2026-07-07 08:30:00
Years of peer-reviewed safety research position cbdMD's broad spectrum CBD for a new era of evidence-based, clinically supported wellness. CHARLOTTE, N.C.
Oasis Launches Hemp-Derived Mixer
2026-07-01 09:00:00
A quadruple-filtered, zero-proof spirit with a resealable, child-resistant cap; ready to enjoy on its own or built into a mocktail CHARLOTTE, N.C., July 1, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD) today announced that its hemp-derived THC ("THC") beverage brand, Herbal Oasis ("Oasis"), has launched Oasis Mixer, a translucent, zero-proof THC spirit that blends into a wide range of beverages without the cloudy, murky appearance common to other THC mixers.
cbdMD Welcomes White House Call for Fair Treatment of Hemp-Derived Products
2026-06-25 14:13:00
As federal reclassification efforts advance and major U.S. exchanges open to compliant operators, cbdMD points to its position as an established, NYSE American–listed company in a maturing cannabinoid category CHARLOTTE, N.C., June 25, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the nation's most recognized and trusted hemp-derived wellness companies, today welcomed the Administration's call urging Congress to ensure the fair treatment of hemp-derived products under federal law and requesting immediate action to revise federal hemp regulation to ensure fair treatment of hemp products under federal law.
cbdMD Appoints Wade Brown Chief Marketing Officer
2026-06-16 10:01:00
Veteran consumer-wellness growth operator to lead multi-brand expansion across DTC, Amazon, retail, and new categories CHARLOTTE, N.C., June 16, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most trusted cannabinoid wellness companies and operator of the cbdMD, Bluebird Botanicals, and Paw CBD brands, along with its THC beverage brand Oasis, today announced the appointment of Wade Brown as Chief Marketing Officer.
cbdMD, Inc. (YCBD) Q2 2026 Earnings Call Transcript
2026-05-14 18:10:51
cbdMD, Inc. (YCBD) Q2 2026 Earnings Call Transcript
2026-05-14 16:10:00
CHARLOTTE, N.C. , May 14, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most trusted CBD companies and operator of the cbdMD, Bluebird Botanicals, and Paw CBD brands, along with its THC beverage brand Oasis, today announced financial results for the second quarter of fiscal year 2026, ended March 31, 2026.
Frequently Asked Questions
-
What is the current cbdMD, Inc. (YCBD) stock price?
-
cbdMD, Inc.(AMEX:YCBD) stock price is $0.6577 in the last trading session. During the trading session, YCBD stock reached the peak price of $2.56 while $0.47 was the lowest point it dropped to. The percentage change in YCBD stock occurred in the recent session was --3.56% while the dollar amount for the price change in YCBD stock was -$-0.02.
-
YCBD's industry and sector of operation?
-
The AMEX listed YCBD is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of YCBD?
-
Francisco Mangual | Senior Vice President of Sales
Lance Blundell | General Counsel
T. Ronan Kennedy | Chief Executive Officer, Chief Financial Officer, Principal Executive Officer & Director
Wade Brown | Chief Marketing Officer
Zeb Booker | Chief Technology Officer -
How many employees does YCBD have?
-
Number of YCBD employees currently stands at 42. YCBD operates from 8845 Red Oak Boulevard, Charlotte, NC 28217, US.
-
Link for YCBD official website?
-
Official Website of YCBD is: https://www.cbdmd.com
-
How do I contact YCBD?
-
YCBD could be contacted at phone #704 445 3060 and can also be accessed through its website. YCBD operates from 8845 Red Oak Boulevard, Charlotte, NC 28217, US.
-
How many shares of YCBD are traded daily?
-
The average number of YCBD shares traded daily for last 3 months was 1.34M.
-
What is the market cap of YCBD currently?
-
The market value of YCBD currently stands at $6.9M with its latest stock price at $0.6577